OCGN Stock: Why Ocugen Shares Are Shooting Higher Today

investorplace2021-09-14

We should never underestimate the power of speculation when it comes to driving stocks up suddenly, particularly in the age of meme stocks and social media investing. We’ve seen it many times, and it ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Annie_ann29
2021-09-14
Annie_ann29
Like plz
SXZX2026
2021-09-14
SXZX2026
It is still not making money
- Annie_ann29:
  Like

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160480771?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-14 10:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160480771","market":"us","top_or_hot":-1,"title":"OCGN Stock: Why Ocugen Shares Are Shooting Higher Today","media":"investorplace","content":"<div>\n<p>We should never underestimate the power of speculation when it comes to driving stocks up suddenly, particularly in the age of meme stocks and social media investing. We’ve seen it many times, and it ...</p>\n\n<a href=\"https://investorplace.com/2021/09/ocgn-stock-why-ocugen-shares-are-shooting-higher-today/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCGN Stock: Why Ocugen Shares Are Shooting Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCGN Stock: Why Ocugen Shares Are Shooting Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-14 10:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/ocgn-stock-why-ocugen-shares-are-shooting-higher-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We should never underestimate the power of speculation when it comes to driving stocks up suddenly, particularly in the age of meme stocks and social media investing. We’ve seen it many times, and it ...</p>\n\n<a href=\"https://investorplace.com/2021/09/ocgn-stock-why-ocugen-shares-are-shooting-higher-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"https://investorplace.com/2021/09/ocgn-stock-why-ocugen-shares-are-shooting-higher-today/","article_id":"1160480771","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160480771","pubTimestamp":1631586353,"columns":[],"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"We should never underestimate the power of speculation when it comes to driving stocks up suddenly, ","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"OCGN股票：为什么Ocugen股价今天飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"We should never underestimate the power of speculation when it comes to driving stocks up suddenly, particularly in the age of meme stocks and social media investing. We’ve seen it many times, and it looks as though it may be happening today. Shares of clinical-stage biotech producer Ocugen(NASDAQ:OCGN)enjoyed a day of steady growth following a significant spike this morning.\nShares of OCGN have spiked since markets opened today, rising to as much as $8.75 up from $7.36. The stock closed out the day higher by 15.8%.\nPrior to the start of the Covid-19 pandemic, Ocugen was primarily invested in the development of treatments for blindness-inducing illnesses. When the pandemic began, its focus pivoted toward vaccine development. Though OCGN stock has not benefitted from regulatory approval like Pfizer(NYSE:PFE) or Moderna(NASDAQ:MRNA), recent reports have indicated that one of Ocugen’s partners may soon receive international approval for its Covid-19 vaccine. In turn, this could provide the long-awaited catalyst for Ocugen and its shareholders.\nWhy It Matters\nOcugen’s partnership is with India-based biopharmaceutical producer Bharat Biotech, the developer of Covaxin, garnered considerable media attention today after a handful of Indian publicationsannouncedBharat expected to receive full emergency-use listing (EUL) from the World Health Organization (WHO) before the end of the month.\nAlthough the vaccine is manufactured in India, the partnership between Bharat Biotech and Ocugen will enable the latter to help commercialize and distribute the vaccine on U.S. soil. Before it does, however, Covaxin will need to secure regulatory approvals in the U.S. With this in mind, media buzz surrounding a potential WHO approval has plenty of investors speculating as to what this means for OCGN stock.\nAs of now, almost everything remains uncertain.\nWhat’s Next for OCGN Stock\nAny type of emergency-use authorization would certainly be good news for Bharat, and likewise for any of its partners.\nThat said, it doesn’t mean that we should regard OCGN stock as having any guaranteed long-term potential for growth, even if the authorization were to pass tomorrow. The WHO approval would certainly boost investor confidence that the U.S. Food and Drug Administration would follow suit, but there is no guarantee. There are already plenty ofvaccine alternativesthat have been faster to gain approval from regulatory agencies.\nIt is also worth noting that Covaxin is not Ocugen’s drug, it is  one that the company would be distributing for an international partner, essentially playing the middle man.\nDevelopments such as these can lead to quick and constant speculation as to what the future looks like for players such as OCGN stock, but that doesn’t mean we should confuse superficial growth with long-term sustainability. Keep an eye on this story — any update from the WHO is sure to get OCGN moving again.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":886647095,"gmtCreate":1631589599917,"gmtModify":1676530583947,"author":{"id":"4088678216292640","authorId":"4088678216292640","name":"Annie_ann29","avatar":"https://static.tigerbbs.com/74b75bf973f051fd1f70b054cc66a45c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4088678216292640","authorIdStr":"4088678216292640"},"htmlText":"Like plz","listText":"Like plz","text":"Like plz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886647095","repostId":1160480771,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":886652114,"gmtCreate":1631588306438,"gmtModify":1676530583514,"author":{"id":"3555288390119843","authorId":"3555288390119843","name":"SXZX2026","avatar":"https://static.tigerbbs.com/77ce9bd591611bdaa026b6c3ada85d2c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3555288390119843","authorIdStr":"3555288390119843"},"htmlText":"It is still not making money&nbsp;","listText":"It is still not making money&nbsp;","text":"It is still not making money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886652114","repostId":1160480771,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5861770,"gmtCreate":1631589607671,"gmtModify":1663233853253,"authorId":4088678216292640,"author":{"id":4088678216292640,"idStr":"4088678216292640","authorId":4088678216292640,"name":"Annie_ann29","avatar":"https://static.tigerbbs.com/74b75bf973f051fd1f70b054cc66a45c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":886652114,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":40,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160480771"}